|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Residues 31-50 of the human structural DNA-binding protein BRAF35.|
|Purification||Antigen affinity chromatography|
|Contains||0.02% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||1:10-1:500|
|Immunohistochemistry (Paraffin) (IHC (P))||1:10-1:500|
|Western Blot (WB)||1:500-1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
The target sequence has 80% sequence homology with mouse protein.
Suggested positive control: antigen standard for HMG20B (transient overexpression lysate).
Mutations of the human BRCA2 gene confer susceptibility to breast cancer. A structural DNA binding component has been identified and is designated as BRCA2-Associated Factor 35 (BRAF35). There is a close association of the BRAF35/BRCA2 complex with conden
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.